Medicare Enrolled
Dr. John Peterson, MD
Medical Oncology · St Petersburg, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Peterson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Peterson?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Peterson
Dr. John Peterson is a medical oncology specialist in St Petersburg, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Peterson performed 138,980 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Peterson received a total of $13,334 from 88 pharmaceutical and/or device companies across 654 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Peterson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 19% volume in FL
$13,334 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗138,980
Medicare services
Top 19% in FL for medical oncology
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
44,880 | $0 | $4 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
25,560 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 17,800 | $43 | $137 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
13,100 | $0 | $5 |
| Denosumab injection (Prolia/Xgeva) | 9,780 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
9,450 | $6 | $23 |
| Anti-nausea injection (aprepitant) | 6,500 | $1 | $5 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,845 | $8 | $29 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,722 | $0 | $3 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,700 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,010 | $1 | $28 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
877 | $10 | $69 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
553 | $94 | $339 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
539 | $63 | $239 |
| Anti-nausea injection (ondansetron/Zofran) | 516 | $0 | $9 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
349 | $97 | $378 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
296 | $1 | $6 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
285 | $47 | $189 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
275 | $22 | $84 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
251 | $12 | $61 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
185 | $132 | $474 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
166 | $1 | $2 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
161 | $15 | $56 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
101 | $1 | $3 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 96 | $133 | $562 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
89 | $3 | $11 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
87 | $22 | $79 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
78 | $9 | $42 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
74 | $48 | $178 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
73 | $17 | $59 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
71 | $4 | $10 |
| New patient office visit, complex (60-74 min) | 60 | $160 | $585 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
57 | $132 | $556 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
55 | $23 | $89 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
46 | $27 | $156 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
44 | $61 | $197 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
42 | $2 | $8 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
40 | $2 | $7 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
38 | $126 | $637 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
35 | $42 | $170 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
28 | $84 | $285 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
24 | $25 | $156 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $127 | $453 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
20 | $50 | $277 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
33.2% high complexity
62.9% medium
3.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,334
Total received (2018-2024)
Avg $1,905/year across 7 years
Top 38% in FL for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
88
Companies
654
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,328
2023
$2,707
2022
$1,462
2021
$132
2020
$415
2019
$2,701
2018
$2,589
Payments by company (2024)
PFIZER INC.
$316
AstraZeneca Pharmaceuticals LP
$285
Novartis Pharmaceuticals Corporation
$253
Incyte Corporation
$238
Takeda Pharmaceuticals U.S.A., Inc.
$208
Janssen Biotech, Inc.
$184
E.R. Squibb & Sons, L.L.C.
$169
Merck Sharp & Dohme LLC
$146
GlaxoSmithKline, LLC.
$136
Celgene Corporation
$123
Lilly USA, LLC
$114
SOBI, INC
$103
Daiichi Sankyo Inc.
$101
Pharmacosmos Therapeutics Inc.
$90
TAIHO ONCOLOGY, INC.
$82
PharmaEssentia USA Corporation
$79
Fennec Pharmaceuticals, Inc.
$73
ABBVIE INC.
$68
Astellas Pharma US Inc
$65
BeiGene USA, Inc.
$55
Exelixis Inc.
$50
Gilead Sciences, Inc.
$48
ARRAY BIOPHARMA INC
$41
Regeneron Healthcare Solutions, Inc.
$36
Dendreon Pharmaceuticals LLC
$35
Janssen Pharmaceuticals, Inc
$26
EMD Serono, Inc.
$25
SpringWorks Therapeutics, Inc.
$24
SERVIER PHARMACEUTICALS LLC
$24
Acrotech Biopharma Inc.
$24
Blueprint Medicines Corporation
$21
Novo Nordisk Inc
$20
Sumitomo Pharma America, Inc.
$18
SHIELD THERAPEUTICS INC
$17
GENZYME CORPORATION
$17
CSL Behring
$13
Top 3 companies account for 25.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,255
AstraZeneca Pharmaceuticals LP
$898
Janssen Biotech, Inc.
$703
E.R. Squibb & Sons, L.L.C.
$698
PFIZER INC.
$678
Lilly USA, LLC
$578
Incyte Corporation
$429
Amgen Inc.
$413
Celgene Corporation
$406
Daiichi Sankyo Inc.
$398
Genentech USA, Inc.
$346
Takeda Pharmaceuticals U.S.A., Inc.
$291
Merck Sharp & Dohme LLC
$286
JAZZ PHARMACEUTICALS INC.
$271
Gilead Sciences, Inc.
$259
GENZYME CORPORATION
$238
Merck Sharp & Dohme Corporation
$234
Novocure Inc.
$225
Astellas Pharma US Inc
$215
GlaxoSmithKline, LLC.
$211
Exelixis Inc.
$159
Kyowa Kirin, Inc.
$154
Allergan Inc.
$154
Kite Pharma, Inc.
$150
EMD Serono, Inc.
$144
Bayer HealthCare Pharmaceuticals Inc.
$144
TerSera Therapeutics LLC
$144
SOBI, INC
$143
Axonics, Inc.
$137
EISAI INC.
$134
CSL Behring
$131
Seagen Inc.
$130
TESARO, Inc.
$125
Dendreon Pharmaceuticals LLC
$124
Eisai Inc.
$120
Seattle Genetics, Inc.
$117
PharmaEssentia USA Corporation
$112
Pharmacosmos Therapeutics Inc.
$109
Puma Biotechnology, Inc.
$90
ABBVIE INC.
$89
Janssen Pharmaceuticals, Inc
$86
TAIHO ONCOLOGY, INC.
$82
Stemline Therapeutics Inc.
$82
Boehringer Ingelheim Pharmaceuticals, Inc.
$75
Fennec Pharmaceuticals, Inc.
$73
BeiGene USA, Inc.
$71
Spectrum Pharmaceuticals Inc.
$70
Pharmacyclics LLC, An AbbVie Company
$65
Ipsen Biopharmaceuticals, Inc
$64
AbbVie, Inc.
$60
Regeneron Healthcare Solutions, Inc.
$57
ARRAY BIOPHARMA INC
$56
Clovis Oncology, Inc.
$55
G1 Therapeutics, Inc.
$54
AMAG Pharmaceuticals, Inc.
$47
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$46
Acrotech Biopharma Inc.
$44
Novo Nordisk Inc
$42
Sumitomo Pharma America, Inc.
$39
Alexion Pharmaceuticals, Inc.
$28
SpringWorks Therapeutics, Inc.
$24
Allergan, Inc.
$24
SERVIER PHARMACEUTICALS LLC
$24
Pharmacyclics LLC, an AbbVie Company
$24
Rigel Pharmaceuticals, Inc.
$23
Blueprint Medicines Corporation
$21
Genmab U.S., Inc.
$20
Aurobindo Pharma USA, Inc.
$20
Shire North American Group Inc
$20
PUMA BIOTECHNOLOGY, INC.
$20
AbbVie Inc.
$20
Array BioPharma Inc.
$18
Sobi, Inc
$18
Global Blood Therapeutics, Inc.
$18
GE HealthCare
$17
Organon LLC
$17
SHIELD THERAPEUTICS INC
$17
Progenics Pharmaceuticals, Inc.
$16
Helsinn Therapeutics (U.S.), Inc.
$15
MEDIVATION FIELD SOLUTIONS LLC
$15
Coherus Biosciences Inc.
$14
NOVARTIS PHARMACEUTICALS CORPORATION
$14
Alnylam Pharmaceuticals Inc.
$14
Agios Pharmaceuticals, Inc.
$14
Epizyme, Inc.,
$13
Collegium Pharmaceutical, Inc.
$12
Dova Pharmaceuticals
$12
Lexicon Pharmaceuticals, Inc.
$10
Top 3 companies account for 21.4% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AUGTYRO · AVYCAZ · AYVAKIT · Abraxane · Afstyla · Alecensa · Aliqopa · Avastin · Axonics · BELEODAQ · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Beleodaq · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CHANTIX · COSELA · CYRAMZA · Cabometyx · DALVANCE · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMEND · ENHERTU · ENJAYMO · ERLEADA · Enhertu · Epkinly · Erleada · FARESTON · FERAHEME · FRUZAQLA · Folotyn · GAMMAGARD · GAUCHER-DISEASE · GAZYVA · GILOTRIF · GIVLAARI · HEMGENIX · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Idelvion · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · OGSIVEO · OJJAARA · ONTRUZANT · OPDIVO · ORGOVYX · OXBRYTA · Oncology · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYLARIFY · Padcev · Pedmark · Perjeta · Pomalyst · Quzyttir · REBLOZYL · Rebinyn · Revlimid · Rubraca · SANDOSTATIN LAR · SARCLISA · SOLIRIS · SOMATULINE DEPOT · SUTENT · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEFLARO · TEVIMBRA · TIBSOVO · TUKYSA · Tavalisse · Tibsovo · Trodelvy · UCERIS · UCERIS TABLETS · ULTOMIRIS · Udenyca · VARUBI · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Venclexta · Vitrakvi · XARELTO · XTANDI · Xermelo · Xofigo · Xospata · Xtampza ER · Xtandi · Yescarta · ZEJULA · ZENPEP · ZEPZELCA · ZOLADEX · Zevalin
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
65
County median income
$70,293
Nearest hospital to ZIP centroid (approximate)
ORLANDO HEALTH BAYFRONT HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Peterson is a mixed practice specialist, with above-average Medicare volume (top 19% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Peterson experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Peterson performed 44,880 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Peterson receive payments from pharmaceutical companies?
Yes. Dr. Peterson received a total of $13,334 from 88 companies across 654 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Peterson's costs compare to other medical oncologists in St Petersburg?
Dr. Peterson's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Peterson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in St Petersburg
Browse medical oncologists in St Petersburg ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology